Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:16 PM
Ignite Modification Date:
2026-03-26 @ 3:16 PM
NCT ID:
NCT07429903
Eligibility Criteria:
Inclusion Criteria:
Age 40 years and older
History of confirmed SARS-CoV-2 infection
Presence of long-COVID symptoms lasting longer than 12 weeks, including one or more of the following:
* Cognitive complaints ("brain fog," memory, attention, or processing speed difficulties)
* Fatigue
* Mood symptoms (e.g., depression)
Consumption of a low-polyphenol (Western) diet
Adequate visual acuity and hearing to complete neuropsychological testing
Screening laboratory results without clinically significant abnormalities that would interfere with study participation
Ability and willingness to provide written informed consent
Exclusion Criteria:
Diagnosis of probable Alzheimer's disease or other dementia (e.g., vascular, Lewy body, frontotemporal)
Other neurological or medical conditions that may cause cognitive impairment
Evidence of Parkinson's disease based on motor examination
Uncontrolled hypertension (systolic BP \>170 mmHg or diastolic BP \>100 mmHg)
Allergy to walnuts
Regular consumption of more than 5 oz of walnuts per week
Current diagnosis of a major psychiatric disorder according to DSM-5 criteria
Alcoholism or substance use disorder
Any condition that, in the investigator's judgment, would make participation unsafe or interfere with study completion
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
40 Years
Study:
NCT07429903
Study Brief:
Protocol Section:
NCT07429903